Literature DB >> 12670597

Improved spectral quality for 3D MR spectroscopic imaging using a high spatial resolution acquisition strategy.

Andreas Ebel1, Andrew A Maudsley.   

Abstract

Spectral quality in (1)H MR spectroscopic imaging (MRSI) of the brain is often significantly degraded in regions subject to local magnetic susceptibility variations, which results in broadened and distorted spectral lineshapes. In this report, a modified acquisition strategy for volumetric echo-planar spectroscopic imaging (3D EPSI) is presented that extends the region of the brain that can be observed. The data are sampled at higher spatial resolution, then corrected for local B(0) shifts and reconstructed such that the final spatial resolution matches that of 3D EPSI data acquired with the conventional lower spatial resolution. Comparison of in vivo data obtained at 1.5 T with these two acquisition schemes shows that the high spatial resolution acquisition provides considerable reduction of spectral linewidths in many problematic brain regions, though with a reduction in signal-to-noise ratio by a factor of approximately 1.4 to 1.6 for the matrix sizes used in this study. However, the effect of the increased noise was largely offset by the improved spectral quality, leading to an overall improvement of the metabolite image quality obtained using automated spectral analysis.

Mesh:

Year:  2003        PMID: 12670597     DOI: 10.1016/s0730-725x(02)00645-8

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  40 in total

1.  Investigation of the PSF-choice method for reduced lipid contamination in prostate MR spectroscopic imaging.

Authors:  Lawrence P Panych; Joseph R Roebuck; Nan-kuei Chen; Yi Tang; Bruno Madore; Clare M Tempany; Robert V Mulkern
Journal:  Magn Reson Med       Date:  2012-11       Impact factor: 4.668

2.  Achieving sufficient spectral bandwidth for volumetric 1H echo-planar spectroscopic imaging at 4 Tesla.

Authors:  Andreas Ebel; Andrew A Maudsley; Michael W Weiner; Norbert Schuff
Journal:  Magn Reson Med       Date:  2005-09       Impact factor: 4.668

3.  Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging.

Authors:  A A Maudsley; A Darkazanli; J R Alger; L O Hall; N Schuff; C Studholme; Y Yu; A Ebel; A Frew; D Goldgof; Y Gu; R Pagare; F Rousseau; K Sivasankaran; B J Soher; P Weber; K Young; X Zhu
Journal:  NMR Biomed       Date:  2006-06       Impact factor: 4.044

4.  Natural linewidth chemical shift imaging (NL-CSI).

Authors:  Adil Bashir; Dmitriy A Yablonskiy
Journal:  Magn Reson Med       Date:  2006-07       Impact factor: 4.668

5.  Correction of local B0 shifts in 3D EPSI of the human brain at 4 T.

Authors:  Andreas Ebel; Andrew A Maudsley; Norbert Schuff
Journal:  Magn Reson Imaging       Date:  2006-11-13       Impact factor: 2.546

6.  Regional distributions of brain glutamate and glutamine in normal subjects.

Authors:  Mohammed Z Goryawala; Sulaiman Sheriff; Andrew A Maudsley
Journal:  NMR Biomed       Date:  2016-06-28       Impact factor: 4.044

7.  Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS.

Authors:  Charlotte J Stagg; Steven Knight; Kevin Talbot; Mark Jenkinson; Andrew A Maudsley; Martin R Turner
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

8.  3D high-resolution imaging of 2-hydroxyglutarate in glioma patients using DRAG-EPSI at 3T in vivo.

Authors:  Zhongxu An; Vivek Tiwari; Jeannie Baxter; Michael Levy; Kimmo J Hatanpaa; Edward Pan; Elizabeth A Maher; Toral R Patel; Bruce E Mickey; Changho Choi
Journal:  Magn Reson Med       Date:  2018-09-14       Impact factor: 4.668

9.  Reproducibility of serial whole-brain MR spectroscopic imaging.

Authors:  A A Maudsley; C Domenig; S Sheriff
Journal:  NMR Biomed       Date:  2010-04       Impact factor: 4.044

10.  Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study.

Authors:  S Andrea Wijtenburg; Susan N Wright; Stephanie A Korenic; Frank E Gaston; Nkemdilim Ndubuizu; Joshua Chiappelli; Robert P McMahon; Hongji Chen; Anya Savransky; Xiaoming Du; Danny J J Wang; Peter Kochunov; L Elliot Hong; Laura M Rowland
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.